Thus, we conclude that Rfx1 expression in the esophageal epithelium is very frequently lost during the progression to esophageal adenocarcinoma, and its loss appears to be a more reliable marker of cancer progression than the up-regulation and then down-regulation of Cdx2 (Figure 5I). This evidence concerns the gene RFX1 and cancer.